Suppr超能文献

导管原位癌放射治疗后局部侵袭性复发增加。

Invasive local recurrence increased after radiation therapy for ductal carcinoma in situ.

作者信息

Guerra Lisa E, Smith Robina M, Kaminski Anna, Lagios Michael D, Silverstein Melvin J

机构信息

Hoag Breast Care Center, One Hoag Dr., Newport Beach, CA 92663, USA.

出版信息

Am J Surg. 2008 Oct;196(4):552-5. doi: 10.1016/j.amjsurg.2008.06.008.

Abstract

BACKGROUND

It is thought that equal numbers of invasive and noninvasive recurrences develop after conservative treatment for ductal carcinoma in situ. We analyzed our data to see if this was true.

METHODS

A prospective database of 878 conservatively treated patients with ductal carcinoma in situ was analyzed.

RESULTS

Among 551 excision patients, there were 88 recurrences. Thirty-five percent were invasive. Among 327 excision plus radiotherapy patients, there were 59 recurrences. Fifty-three percent were invasive. In an attempt to predict which patients develop invasive recurrences, prolonged time to recurrence was the only statistically significant factor.

CONCLUSIONS

The median time to local recurrence for irradiated patients was more than twice as long when compared with nonirradiated patients, during which there is more time for local recurrence to progress to invasion. Irradiated patients had more breast scarring, making diagnosis by palpation and mammography harder. Irradiated patients develop invasive recurrences at a statistically higher rate than nonirradiated patients. Follow-up evaluation with magnetic resonance imaging should be considered.

摘要

背景

人们认为,导管原位癌保守治疗后发生的浸润性复发和非浸润性复发数量相等。我们分析了我们的数据,以确定这是否属实。

方法

分析了一个包含878例导管原位癌保守治疗患者的前瞻性数据库。

结果

在551例接受手术切除的患者中,有88例复发。其中35%为浸润性复发。在327例接受手术切除加放疗的患者中,有59例复发。其中53%为浸润性复发。为了预测哪些患者会发生浸润性复发,复发时间延长是唯一具有统计学意义的因素。

结论

与未接受放疗的患者相比,接受放疗的患者局部复发的中位时间延长了一倍多,在此期间,局部复发进展为浸润的时间更多。接受放疗的患者乳房瘢痕更多,使得触诊和乳房X线摄影诊断更加困难。接受放疗的患者发生浸润性复发的统计学概率高于未接受放疗的患者。应考虑采用磁共振成像进行随访评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验